These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32868512)

  • 1. Subarachnoid neurocysticercosis: emerging concepts and treatment.
    Nash TE; O'Connell EM
    Curr Opin Infect Dis; 2020 Oct; 33(5):339-346. PubMed ID: 32868512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune responses during Taenia solium Neurocysticercosis infection and treatment.
    Prodjinotho UF; Lema J; Lacorcia M; Schmidt V; Vejzagic N; Sikasunge C; Ngowi B; Winkler AS; Prazeres da Costa C
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008005. PubMed ID: 32298263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular Neurocysticercosis: Experience and Long-Term Outcome from a Tertiary Referral Center in the United States.
    Nash TE; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2018 Jun; 98(6):1755-1762. PubMed ID: 29692305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis of subarachnoid cysts of Taenia solium reveals mechanisms for uncontrolled proliferation and adaptations to the microenvironment.
    Orrego MA; Szczesniak MW; Vasquez CM; Verastegui MR; Bustos JA; Garcia HH; Nash TE;
    Sci Rep; 2024 May; 14(1):11833. PubMed ID: 38782926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid use in neurocysticercosis.
    Nash TE; Mahanty S; Garcia HH;
    Expert Rev Neurother; 2011 Aug; 11(8):1175-83. PubMed ID: 21797658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis.
    Carrillo Mezo R; Lara García J; Arroyo M; Fleury A
    Acta Trop; 2015 Dec; 152():60-65. PubMed ID: 26327445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.
    Rodriguez S; Dorny P; Tsang VC; Pretell EJ; Brandt J; Lescano AG; Gonzalez AE; Gilman RH; Garcia HH;
    J Infect Dis; 2009 May; 199(9):1345-52. PubMed ID: 19358669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Screening for Urine Antigens to Detect Asymptomatic Subarachnoid Neurocysticercosis: A Pilot Study in Northern Peru.
    McCleery E; Allen SE; Moyano LM; Gamboa R; Vilchez P; Muro C; Castillo Y; Dorny P; Garcia HH; O'Neal SE;
    Am J Trop Med Hyg; 2020 Sep; 103(3):1125-1128. PubMed ID: 32602434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocysticercosis-induced hemiballismus in a child.
    Karnik PS; Tullu MS; David JJ; Ghildiyal RG
    J Child Neurol; 2011 Jul; 26(7):904-6. PubMed ID: 21427444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment.
    Orrego MA; Verastegui MR; Vasquez CM; Garcia HH; Nash TE;
    Int J Parasitol; 2022 May; 52(6):377-383. PubMed ID: 35182540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory Diagnosis of Neurocysticercosis (Taenia solium).
    Garcia HH; O'Neal SE; Noh J; Handali S;
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29875195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and culture of proliferative cells in abnormal Taenia solium larvae: Role in the development of racemose neurocysticercosis.
    Orrego MA; Verastegui MR; Vasquez CM; Koziol U; Laclette JP; Garcia HH; Nash TE;
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009303. PubMed ID: 33750965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA.
    Nguekam ; Zoli AP; Ongolo-Zogo P; Dorny P; Brandt J; Geerts S
    Parasite; 2003 Mar; 10(1):65-8. PubMed ID: 12669351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Keiser PB; Nash TE
    Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of neurocysticercosis.
    Nash TE; Garcia HH
    Nat Rev Neurol; 2011 Sep; 7(10):584-94. PubMed ID: 21912406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurocysticercosis: report of three cases and recommendations of treatment].
    Alvarez Rodríguez E; Torres-Gárate R; Gutiérrez Larráinzar A; Cabello J; Espinós Pérez D
    An Med Interna; 2004 Aug; 21(8):382-6. PubMed ID: 15373721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocysticercosis: radiologic-pathologic correlation.
    Kimura-Hayama ET; Higuera JA; Corona-Cedillo R; Chávez-Macías L; Perochena A; Quiroz-Rojas LY; Rodríguez-Carbajal J; Criales JL
    Radiographics; 2010 Oct; 30(6):1705-19. PubMed ID: 21071384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis.
    Tuero I; Palma S; Cabeza F; Saleemi S; Rodriguez S; Gonzales I; Mayta H; Mahanty S; Garcia HH; Gilman RH;
    PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004143. PubMed ID: 26506532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
    Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA;
    Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.